Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PBR vs GSK✓SelectedUSD · GSKPBR vs GSK performance historyLatest closeAs of-1.72%11/20
Stock and ETF performance explorer

PBR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+40.1%
GSK return
+53.4%
Excess return
-13.3%
Maximum drawdown
-38.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.7%-0.1%-1.6%-1.7%
7D-12.7%-5.3%-7.4%-12.6%
30D-37.6%-3.7%-33.9%-37.5%
3M-13.3%-7.3%-6.1%-13.0%
6M-16.3%-4.2%-12.0%-16.2%
YTD+41.0%+0.9%+40.1%+39.0%
1Y+30.7%+7.3%+23.4%+27.8%
3Y+40.1%+52.7%-12.7%+18.3%
All+40.1%+53.4%-13.3%+18.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling